Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2024 · 10-Q
Revenue$7.85M$7.85M+0.4% vs Q1 2023 Net Income$556.24K$556.24K−27.5% vs Q1 2023 EPS Diluted$0.07$0.07−22.2% vs Q1 2023 Operating Income$821,223−51.2% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived-$814,587N/M Margins · derivedOperating margin10.5%−11.1 pt vs Q1 2023
Net margin7.1%−2.7 pt vs Q1 2023
ended Feb 29, 2024 · filed Apr 15, 2024 · 46 d after period end